Geneos Therapeutics

About:

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Website: https://geneostx.com/

Top Investors: Korea Investment Partners, Inovio Pharmaceuticals, Flerie Invest, 3B Future Health Fund, Sante Ventures

Description:

Geneos is developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment. The company's technology is designed to identify relevant neoantigen targets from individual patient tumors to develop novel treatments for cancer, providing patients with tumor targeted immunotherapies to cure their disease.

Total Funding Amount:

$49.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Plymouth Meeting, Pennsylvania, United States

Founded Date:

2016-08-01

Founders:

Niranjan Y. Sardesai

Number of Employees:

1-10

Last Funding Date:

2023-09-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai